tiprankstipranks
KalVista submits New Drug Application to FDA for sebetralstat
PremiumThe FlyKalVista submits New Drug Application to FDA for sebetralstat
1M ago
KalVista presents data on persisting unmet needs in Hereditary Angioedema
PremiumThe Fly
KalVista presents data on persisting unmet needs in Hereditary Angioedema
2M ago
KalVista announces publication of data from Phase 3 KONFIDENT trial
PremiumThe Fly
KalVista announces publication of data from Phase 3 KONFIDENT trial
2M ago
KalVista Pharmaceuticals Announces Executive Leadership Transition
PremiumCompany AnnouncementsKalVista Pharmaceuticals Announces Executive Leadership Transition
5M ago
KalVista appoints Benjamin Palleiko as CEO
PremiumThe Fly
KalVista appoints Benjamin Palleiko as CEO
5M ago
KalVista presents additional Phase 3 KONFIDENT data at AAAAI meeting
PremiumThe Fly
KalVista presents additional Phase 3 KONFIDENT data at AAAAI meeting
5M ago
KalVista 7.016M share Spot Secondary priced at $15.25
PremiumThe FlyKalVista 7.016M share Spot Secondary priced at $15.25
5M ago
KalVista Pharmaceuticals Ends Stock Sale Agreement with Cantor
PremiumCompany Announcements
KalVista Pharmaceuticals Ends Stock Sale Agreement with Cantor
5M ago
KalVista announces common stock, warrants offering
PremiumThe Fly
KalVista announces common stock, warrants offering
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100